Capsular Polysaccharide Expression in Commensal Streptococcus Species: Genetic and Antigenic Similarities to Streptococcus pneumoniae
Encapsulated Streptococcus mitis and oralis which can be potentially be used for development of vaccine against pneumococcal disease.
NON-PNEUMOCOCCAL STREPTOCOCCI CROSS-REACTING WITH SEROTYPE 1 PNEUMOCOCCI IN US ADULTS ENROLLED IN A PNEUMOCOCCAL CARRIAGE SURVEY
Non-pneumococcal streptococci confounding PCR serotyping of Streptococcus pneumoniaein US colonized adults
The CDC Technology Transfer Office (TTO) is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize:
Encapsulated Streptococcus Compositions & Methods for Pneumococcal Vaccine, Probiotic and Diagnostic Assay Development. For collaboration opportunities, please contact CDC TTO at firstname.lastname@example.org or 1-404-639-1330.